Category Medicine and Healthcare
Press Release
Marijuana Rescheduling: The DEA's Dirty Little Cannabis Secret: Meet the 800-Pound Marijuana Gorilla
All the news about the DEA administrator and Rescheduling marijuana means absolutely nothing if the quota system remains untouched. Much attention has been given to breaking Ole Miss's monopoly and who becomes the next DEA Administrator. But the real news isn't about who's appointed-it's what the DEA does with the quota system. Read More
Press Release
CASI Pharmaceuticals Appoints David Cory as Chief Executive Officer to Lead U.S. Company Focused on Clinical Development of CID-103, a Potential Best in Class Anti-CD38 Program
-- David Cory is an industry veteran, bringing more than 30 years of operational experience, in private and public, emerging-stage biotech and large pharma companies with an established track record of building and leading high performing operating teams and financing in the capital markets with over $1B+ raised and multiple company exits by acquisition -- CID-103 is a potential best in class, anti-CD38 monoclonal antibody, currently dosing in a multi-center Phase 1/2 study in adults with chronic immune thrombocytopenia (ITP); IND submitted to support future clinical trials in adults with renal allograft antibody-mediated rejection (AMR) Read More
Press Release
Protagonist Announces Submission of NDA for First Icotrokinra U.S. FDA Approval Aiming to Revolutionize Treatment Paradigm for Adults and Adolescents with Plaque Psoriasis
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor Filing based on unprecedented data package that met all primary endpoints across four Phase 3 studies, including head-to-head superiority comparisons versus deucravacitinib and evaluation of difficult to treat skin sites Submission underscores potential to offer moderate-to-severe plaque psoriasis patients the standout combination of complete skin clearance, favorable safety profile, and simplicity of a once-daily pill Read More
Press Release
DEA's Cannabis Cartel: A Federal Marijuana Scam That Sabotaged Science, Blocked Patients, and Protected Power
As thousands suffer without access to FDA-approved cannabis treatments, MMJ BioPharma Cultivation is waging a David vs. Goliath legal war against the DEA's decade-long deception-and incoming Administrator Terrance Cole must decide whether to continue the cover-up or finally put patients over politics. Read More
Press Release
Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin
New data shows Telomir-1 fully reverses STAT1 gene silencing by DNA methylation - a key immune regulator suppressed in cancer - delivering stronger epigenetic effects than Paclitaxel or Rapamycin in aggressive PC3 tumor models. Read More
Press Release
DEA Whistle Blower-MMJ CEO Duane Boise Blows the Whistle on DEA Stonewalled Cannabis Research
MMJ CEO Duane Boise Exposes DEA Corruption in National Interview: Calls for Dismissal of Officials Blocking FDA Medical Marijuana Trials Full Interview with MMJ CEO Duane Boise to Air Today @ 9.am ET on Cannabis Coast to Coast News. Terrance Cole, the nominee for DEA Administrator, must confront this DEA rot head on. The agency's marijuana program is a train wreck. The public deserves answers. And legitimate companies like MMJ BioPharma Cultivation deserve justice. Read More
Press Release
Boise Urologist Dr. Austen Slade Hosts Leading Physicians for Advanced Surgical Training
Boise's growing prominence in advanced urologic care was highlighted recently when Dr. Austen Slade welcomed visiting physicians from Stanford University and the University of Washington to observe and study the HoLEP (Holmium Laser Enucleation of the Prostate) procedure under his guidance. Read More
Press Release
The DEA's BILLION Dollar Marijuana Scandal: A DEA Regulatory Betrayal of Science and Public Trust
WHERE IS DEA'S DEPUTY THOMAS PREVOZNIK HIDING? Bright Green Corp: The DEA-Enabled Stock Market Swindle Files For Bankruptcy. "Terrance Cole, the nominee for DEA Administrator, must confront this DEA rot head on. The agency's marijuana program is a train wreck. The public deserves answers. And legitimate companies like MMJ BioPharma deserve justice." stated Duane Boise, CEO MMJ. Read More
Press Release
Dr. Sadia Ali Joins Ankle & Foot Centers of America, Opening New Office in Acworth
A double board-certified foot and ankle surgeon with expertise in trauma, sports injuries, and complex reconstructive procedures, Dr. Ali will expand access to comprehensive podiatric care in the growing Acworth community. Read More
Press Release
Welcome to DEA Judge McLooney's Marijuana Kangaroo Court-DEA Grants Itself a Favor, Denies MMJ Cannabis Drug Relief
While Patients Suffer, DEA Manipulates Due Process to Cover Its Cannabis Crimes. The DEA blocking federally compliant pharmaceutical research is not just bureaucratic incompetence; it is systemic negligence bordering on malpractice. Read More
Press Release
AATec Medical and Northway Biotech Announce Partnership to Develop Industrial Production Process for ATL-105 Targeting Lung Disease
Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action Read More
Press Release
Mentavi's Diagnostic Evaluation Offers Critical Mental-Health Support to Primary Care Clinicians
Mentavi's innovative online asynchronous assessment, validated in a clinical study presented at the 10th World Congress on ADHD, provides clinicians with an efficient, comprehensive diagnostic mental health evaluation at an affordable price for their patients. Read More
Press Release
DEA Crushes Illegal Marijuana - But Still Blocks MMJ's Legal Cannabis Drug for Huntington's
While busting cartels, DEA continues war on science and suffering patients. Duane Boise, CEO of MMJ International Holdings, expressed frustration over the contrasting approaches of federal agencies, stating, "While the FDA is facilitating medical innovation, the DEA's hindrance not only blocks scientific progress but also contradicts directives aimed at revitalizing domestic manufacturing." This situation starkly contrasts with the "Buy American" initiative endorsed by President Trump, which was intended to strengthen U.S. drug production capabilities and reduce dependence on foreign manufacturers. Read More
Press Release
Jeff Clark's Final Vision 2025: Best Tech Stocks to Buy
Jeff Clark's Final Vision 2025 reveals expert-vetted tech stock picks in AI, biotech, and quantum computing-built on proven options strategies, chaos pattern analysis, and actionable investment timelines for serious traders seeking growth in a volatile market. Read More
Press Release
Unbreakable Brain: Reverse Memory Decline Naturally
A Groundbreaking 28-Day Brain Health Plan from Dr. Will Mitchell Uses Coconut Oil, B Vitamins, and Science-Backed Nutrition to Help Adults Over 45 Combat Memory Decline, Restore Mental Clarity, and Build Long-Term Cognitive Resilience in 2025 Read More
Press Release
MIRA Reports Clear Reversal of Anxiety-Related Behavior in Animal Model Using SKNY-1, an Oral Drug Candidate for Obesity and Nicotine Addiction Under Definitive Agreement for Acquisition
SKNY-1 was previously shown to achieve up to 30% weight loss, reverse nicotine craving, and preserve muscle mass in an animal model-and is designed to avoid the CNS side effects that halted earlier CB1-targeting drugs Read More
Press Release
Reverse Kidney Disease Naturally: Proven 3-Phase Plan
The Chronic Kidney Disease Solution introduces a science-backed 3-phase system for natural kidney support in 2025 - focusing on the gut-kidney axis, inflammation reduction, and lifestyle-based recovery across all CKD stages. Read More
Press Release